Home › Funds › Capital International, Inc./CA/ › ABT

Capital International, Inc./CA/ position in ABT

ABBOTT LABORATORIES · Health Care

Capital International, Inc./CA/ reported holding 952,707 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$94.2M, representing 0.68% of its reported portfolio and ranking #39 among its reported holdings. Capital International, Inc./CA/ has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)952.71K sh
Reported value held$94.16M
Portfolio Weight0.68%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital International, Inc./CA/'s ABT position evolved

Capital International, Inc./CA/ first disclosed a stake in ABT in Q3 2023 at 324,396 shares (US$31.4M). The position peaked in Q3 2025 at 965,236 shares, worth US$129.3M. Across 13 filings, Capital International, Inc./CA/ increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 952,707 shares valued at US$94.2M — a reduction of -7,357 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 324.40K $31.42M New
Q4 2023 397.80K $43.79M Add
Q1 2024 489.44K $55.63M Add
Q2 2024 570.09K $59.24M Add
Q3 2024 600.79K $68.50M Add
Q4 2024 686.83K $77.69M Add
Q1 2025 728.26K $96.60M Add
Q2 2025 821.20K $111.69M Add
Q3 2025 965.24K $129.28M Add
Q4 2025 1.02M $128.08M Add
Q1 2026 933.49K $95.84M Reduce
Q2 2026 960.06K $87.12M Add
Q3 2026 952.71K $94.16M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Capital International, Inc./CA/ held ABT?

Capital International, Inc./CA/ has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Capital International, Inc./CA/'s current position in ABT?

As of Q3 2026, Capital International, Inc./CA/ holds 952.71K shares of ABT (ABBOTT LABORATORIES), valued at $94.16M, representing 0.68% of its reported portfolio and ranking #39.

Has Capital International, Inc./CA/ been buying or selling ABT?

In the latest 13F filing (Q3 2026), Capital International, Inc./CA/ reduced its position in ABT. The position peaked in Q3 2025 at 965.24K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.